Deka developed the new insulin pump, called Twiist, and received Food and Drug Administration clearance in March for the device to be used by people with Type 1 diabetes. Sequel will market the device ...
Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.